AstraZeneca acquires oral PCSK9 inhibitors from Dogma Therapeutics

pharmanewsdaily- September 19, 2020 0

Pharma giant AstraZeneca has signed a deal to acquire a preclinical oral PCSK9 inhibitor asset from Dogma Therapeutics, a portfolio company of Viva Biotech. The ... Read More

NeuroBo, Gemphire merger wrapped up to form neurodegenerative disease company

pharmanewsdaily- January 13, 2020 0

NeuroBo Pharmaceuticals,  a Boston-based clinical-stage pharma company, has wrapped up its previously announced merger with Gemphire Therapeutics, a Michigan-based clinical-stage biopharma company focused on developing ... Read More